Picture of Medifast logo

MED — Medifast News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesAdventurousSmall CapSuper Stock

Medifast Inc reports results for the quarter ended in March - Earnings Summary

* Medifast Inc  MED.N  reported quarterly adjusted earnings
of
$3.67​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for earnings of $2.40 per
share.
    * Revenue fell 16.4% to $348.98 million from a year ago;
analysts
expected $319.52 million. 
    * Medifast Inc's reported EPS for the quarter was $3.67​.
    * The mean earnings estimate of analysts had fallen by
about 26.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Medifast Inc shares had fallen by 11.6% this quarter and
lost 20.5% so far this year.
    * The company reported quarterly net income of $39.97
million.
    * Wall Street's median 12-month price target for Medifast
Inc is
$94.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
1 at 10:05 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      2.40           3.67           Beat
 Dec. 31 2022      2.22           3.27           Beat
 Sep. 30 2022      1.91           3.27           Beat
 Jun. 30 2022      3.23           3.42           Beat

Recent news on Medifast

See all news